Open Access Article November 10, 2024

11 Pages

Management of Cardiogenic Shock in Mitral Valve Diseases: A Review Article

Authors

Ashraf Ahmed1,* , Mohamed Badheeb2 , Kayla Boyea3 , Rasha Kaddoura4 , Fabricio Webber5 , Todd Lane6 , Gilead Lancaster7

  1. Department of Internal Medicine, Bridgeport Hospital, Yale New Haven Health, CT, USA.
  2. Internal Medicine Department, Bridgeport Hospital, Yale New Haven Health, CT, USA
  3. Internal Medicine Department, Bridgeport Hospital, Yale New Haven Health, CT, USA
  4. Department of Pharmacy, Heart Hospital, Hamad Medical Corporation, Doha, Qatar
  5. Department of Cardiovascular Diseases, University of Miami, FL, USA
  6. Department of Academic Affairs, Bridgeport Hospital, CT, USA
  7. Department of Cardiovascular Diseases, Bridgeport Hospital, Yale New Haven Health, CT, USA
  8. * Author to whom correspondence should be addressed.

Journal of Heart Valve Disease Innovation 2024, 29(1), 60-70; https://doi.org/10.36923/jhvd.v29i1.239

Download PDF Share Ask AI (Dimensions)

Abstract

Despite advances in the field of cardiology, cardiogenic shock (CS) remains a management dilemma with a high mortality rate. While most cases of CS are secondary to acute coronary syndrome (ACS), approximately one-fifth can be attributed to delayed mechanical complications of ACS, such as arrhythmia, cardiac tamponade, or valvular heart diseases. The coexistence of CS and mitral valve diseases (MVDs) further complicates clinical presentation, diagnosis, and management strategies. Surgical interventions are considered the gold standard for managing MVDs in the context of CS. However, these patients are often at extreme surgical risk and may not achieve favorable outcomes. Catheter-based interventions have garnered increasing interest, but despite their promising results, most trials have excluded patients in unstable or critical conditions. Pharmacological and mechanical circulatory support provide a bridge to definitive transcatheter or surgical intervention.

Article information

Keywords
Mitral Valve diseasesCardiogenic Shockpercutaneous mitral valve repairMechanical Circulatory SupportInotropic Agents
Section
Articles
Issue
Vol. 29 No. 1 (2024)
Submitted
July 25, 2024
Accepted
October 26, 2024
Published
November 10, 2024
Corresponding author
Ashraf Ahmed
Check for updates
Check for updates

References

  1. [1]. D. Kolte et al., “Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST?Elevation Myocardial Infarction in the United States,” Journal of the American Heart Association, vol. 3, no. 1, p. e000590, doi: 10.1161/JAHA.113.000590. DOI: https://doi.org/10.1161/JAHA.113.000590 Google Scholar PubMed Crossref WorldCat
  2. [2]. P. Lurz and C. Besler, “Mitral Regurgitation in Cardiogenic Shock,” JACC: Cardiovascular Interven-tions, vol. 14, no. 1, pp. 12–14, Jan. 2021, doi: 10.1016/j.jcin.2020.09.030. DOI: https://doi.org/10.1016/j.jcin.2020.09.030 Google Scholar PubMed Crossref WorldCat
  3. [3]. E. Lüsebrink, S. Massberg, and M. Orban, “Ten things ICU specialists need to know about new valvular procedures in interventional cardiology,” Intensive Care Med, vol. 46, no. 1, pp. 102–106, Jan. 2020, doi: 10.1007/s00134-019-05824-6. DOI: https://doi.org/10.1007/s00134-019-05824-6 Google Scholar PubMed Crossref WorldCat
  4. [4]. M. Enriquez-Sarano, C. W. Akins, and A. Vahanian, “Mitral regurgitation,” Lancet, vol. 373, no. 9672, pp. 1382–1394, Apr. 2009, doi: 10.1016/S0140-6736(09)60692-9. DOI: https://doi.org/10.1016/S0140-6736(09)60692-9 Google Scholar PubMed Crossref WorldCat
  5. [5]. S. Bernard, S. Deferm, and P. B. Bertrand, “Acute valvular emergencies,” European Heart Journal. Acute Cardiovascular Care, vol. 11, no. 8, pp. 653–665, Aug. 2022, doi: 10.1093/ehjacc/zuac086. DOI: https://doi.org/10.1093/ehjacc/zuac086 Google Scholar PubMed Crossref WorldCat
  6. [6]. M. Akodad, G. Schurtz, J. Adda, F. Leclercq, and F. Roubille, “Management of valvulopathies with acute severe heart failure and cardiogenic shock,” Archives of Cardiovascular Diseases, vol. 112, no. 12, pp. 773–780, Dec. 2019, doi: 10.1016/j.acvd.2019.06.009. DOI: https://doi.org/10.1016/j.acvd.2019.06.009 Google Scholar PubMed Crossref WorldCat
  7. [7]. P. Ponikowski et al., “2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC,” Eur Heart J, vol. 37, no. 27, pp. 2129–2200, Jul. 2016, doi: 10.1093/eurheartj/ehw128. DOI: https://doi.org/10.1093/eurheartj/ehw128 Google Scholar PubMed Crossref WorldCat
  8. [8]. P. Shah and J. A. Cowger, “Cardiogenic shock,” Crit Care Clin, vol. 30, no. 3, pp. 391–412, Jul. 2014, doi: 10.1016/j.ccc.2014.03.001. DOI: https://doi.org/10.1016/j.ccc.2014.03.001 Google Scholar PubMed Crossref WorldCat
  9. [9]. R. Kaddoura and S. Elbdri, “Current evidence in the diagnosis and management of cardiogenic shock complicating acute coronary syndrome,” RCM, vol. 22, no. 3, Art. no. 3, Sep. 2021, doi: 10.31083/j.rcm2203078. DOI: https://doi.org/10.31083/j.rcm2203078 Google Scholar PubMed Crossref WorldCat
  10. [10]. C. Vahdatpour, D. Collins, and S. Goldberg, “Cardiogenic Shock,” Journal of the American Heart Asso-ciation, vol. 8, no. 8, p. e011991, Apr. 2019, doi: 10.1161/JAHA.119.011991. DOI: https://doi.org/10.1161/JAHA.119.011991 Google Scholar PubMed Crossref WorldCat
  11. [11]. “SCAI clinical expert consensus statement on the classification of cardiogenic shock - Baran - 2019 - Catheterization and Cardiovascular Interventions - Wiley Online Library.” Accessed: Oct. 20, 2024. [Online]. Available: https://onlinelibrary-wiley-com.qulib.idm.oclc.org/doi/full/10.1002/ccd.28329 Google Scholar PubMed Crossref WorldCat
  12. [12]. S. S. Naidu et al., “SCAI SHOCK Stage Classification Expert Consensus Update: A Review and Incor-poration of Validation Studies: This statement was endorsed by the American College of Cardiology (ACC), American College of Emergency Physicians (ACEP), American Heart Association (AHA), Euro-pean Society of Cardiology (ESC) Association for Acute Cardiovascular Care (ACVC), International So-ciety for Heart and Lung Transplantation (ISHLT), Society of Critical Care Medicine (SCCM), and Socie-ty of Thoracic Surgeons (STS) in December 2021.,” Journal of the Society for Cardiovascular Angi-ography & Interventions, vol. 1, no. 1, Jan. 2022, doi: 10.1016/j.jscai.2021.100008. DOI: https://doi.org/10.1016/j.jscai.2021.100008 Google Scholar PubMed Crossref WorldCat
  13. [13]. D. D. Backer et al., “Comparison of Dopamine and Norepinephrine in the Treatment of Shock,” New England Journal of Medicine, vol. 362, no. 9, pp. 779–789, Mar. 2010, doi: 10.1056/NEJMoa0907118. DOI: https://doi.org/10.1056/NEJMoa0907118 Google Scholar PubMed Crossref WorldCat
  14. [14]. B. Levy, P. Perez, J. Perny, C. Thivilier, and A. Gerard, “Comparison of norepinephrine-dobutamine to epinephrine for hemodynamics, lactate metabolism, and organ function variables in cardiogenic shock. A prospective, randomized pilot study,” Crit Care Med, vol. 39, no. 3, pp. 450–455, Mar. 2011, doi: 10.1097/CCM.0b013e3181ffe0eb. DOI: https://doi.org/10.1097/CCM.0b013e3181ffe0eb Google Scholar PubMed Crossref WorldCat
  15. [15]. B. Levy et al., “Epinephrine Versus Norepinephrine for Cardiogenic Shock After Acute Myocardial Infarc-tion,” J Am Coll Cardiol, vol. 72, no. 2, pp. 173–182, Jul. 2018, doi: 10.1016/j.jacc.2018.04.051. DOI: https://doi.org/10.1016/j.jacc.2018.04.051 Google Scholar PubMed Crossref WorldCat
  16. [16]. M. J. García-González, A. Domínguez-Rodríguez, J. J. Ferrer-Hita, P. Abreu-González, and M. B. Muñoz, “Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics,” Eur J Heart Fail, vol. 8, no. 7, pp. 723–728, Nov. 2006, doi: 10.1016/j.ejheart.2006.01.007. DOI: https://doi.org/10.1016/j.ejheart.2006.01.007 Google Scholar PubMed Crossref WorldCat
  17. [17]. J. T. Fuhrmann et al., “Levosimendan is superior to enoximone in refractory cardiogenic shock compli-cating acute myocardial infarction,” Crit Care Med, vol. 36, no. 8, pp. 2257–2266, Aug. 2008, doi: 10.1097/CCM.0b013e3181809846. DOI: https://doi.org/10.1097/CCM.0b013e3181809846 Google Scholar PubMed Crossref WorldCat
  18. [18]. T. Husebye et al., “Levosimendan in acute heart failure following primary percutaneous coronary interven-tion-treated acute ST-elevation myocardial infarction. Results from the LEAF trial: a randomized, place-bo-controlled study,” Eur J Heart Fail, vol. 15, no. 5, pp. 565–572, May 2013, doi: 10.1093/eurjhf/hfs215. DOI: https://doi.org/10.1093/eurjhf/hfs215 Google Scholar PubMed Crossref WorldCat
  19. [19]. “Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock | New England Journal of Medicine.” Accessed: Oct. 20, 2024. [Online]. Available: https://www-nejm-org.qulib.idm.oclc.org/doi/full/10.1056/NEJMoa2026845 Google Scholar PubMed Crossref WorldCat
  20. [20]. “Vasopressors and Inotropes in Acute Myocardial Infarction Related Cardiogenic Shock: A Systematic Review and Meta-Analysis - PubMed.” Accessed: Oct. 20, 2024. [Online]. Available: https://pubmed-ncbi-nlm-nih-gov.qulib.idm.oclc.org/32629772/ Google Scholar PubMed WorldCat
  21. [21]. R. Kaddoura et al., “Vasoactive pharmacologic therapy in cardiogenic shock: a critical review,” J Drug Assess, vol. 10, no. 1, pp. 68–85, 2021, doi: 10.1080/21556660.2021.1930548. DOI: https://doi.org/10.1080/21556660.2021.1930548 Google Scholar PubMed Crossref WorldCat
  22. [22]. H. Thiele et al., “Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock,” New England Journal of Medicine, vol. 367, no. 14, pp. 1287–1296, Oct. 2012, doi: 10.1056/NEJMoa1208410. DOI: https://doi.org/10.1056/NEJMoa1208410 Google Scholar PubMed Crossref WorldCat
  23. [23]. “Venoarterial extracorporeal membrane oxygenation or standard care in patients with cardiogenic shock complicating acute myocardial infarction: the multicentre, randomised EURO SHOCK trial - PubMed.” Accessed: Oct. 20, 2024. [Online]. Available: https://pubmed-ncbi-nlm-nih-gov.qulib.idm.oclc.org/37334659/ Google Scholar PubMed WorldCat
  24. [24]. H. Thiele et al., “Extracorporeal Life Support in Infarct-Related Cardiogenic Shock,” New England Jour-nal of Medicine, vol. 389, no. 14, pp. 1286–1297, Oct. 2023, doi: 10.1056/NEJMoa2307227. DOI: https://doi.org/10.1056/NEJMoa2307227 Google Scholar PubMed Crossref WorldCat
  25. [25]. M. Seyfarth et al., “A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction,” J Am Coll Cardiol, vol. 52, no. 19, pp. 1584–1588, Nov. 2008, doi: 10.1016/j.jacc.2008.05.065. DOI: https://doi.org/10.1016/j.jacc.2008.05.065 Google Scholar PubMed Crossref WorldCat
  26. [26]. D. M. Ouweneel et al., “Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction,” J Am Coll Cardiol, vol. 69, no. 3, pp. 278–287, Jan. 2017, doi: 10.1016/j.jacc.2016.10.022. DOI: https://doi.org/10.1016/j.jacc.2016.10.026 Google Scholar PubMed Crossref WorldCat
  27. [27]. J. E. Møller et al., “Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock,” New England Journal of Medicine, vol. 390, no. 15, pp. 1382–1393, Apr. 2024, doi: 10.1056/NEJMoa2312572. DOI: https://doi.org/10.1056/NEJMoa2312572 Google Scholar PubMed Crossref WorldCat
  28. [28]. V. T. Nkomo, J. M. Gardin, T. N. Skelton, J. S. Gottdiener, C. G. Scott, and M. Enriquez-Sarano, “Burden of valvular heart diseases: a population-based study,” Lancet, vol. 368, no. 9540, pp. 1005–1011, Sep. 2006, doi: 10.1016/S0140-6736(06)69208-8. DOI: https://doi.org/10.1016/S0140-6736(06)69208-8 Google Scholar PubMed Crossref WorldCat
  29. [29]. S. Douedi and H. Douedi, “Mitral Regurgitation,” in StatPearls, Treasure Island (FL): StatPearls Pub-lishing, 2023. Accessed: Oct. 29, 2023. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK553135/ Google Scholar PubMed WorldCat
  30. [30]. F. N. Delling and R. S. Vasan, “Epidemiology and Pathophysiology of Mitral Valve Prolapse,” Circula-tion, vol. 129, no. 21, pp. 2158–2170, May 2014, doi: 10.1161/CIRCULATIONAHA.113.006702. DOI: https://doi.org/10.1161/CIRCULATIONAHA.113.006702 Google Scholar PubMed Crossref WorldCat
  31. [31]. “2021 ESC/EACTS Guidelines for the management of valvular heart disease | European Heart Journal | Oxford Academic.” Accessed: Oct. 20, 2024. [Online]. Available: https://academic-oup-com.qulib.idm.oclc.org/eurheartj/article/43/7/561/6358470 Google Scholar PubMed WorldCat
  32. [32]. S. N. Shah and S. Sharma, “Mitral Stenosis,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2023. Accessed: Oct. 29, 2023. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK430742/ Google Scholar PubMed WorldCat
  33. [33]. [C. R. Thompson et al., “Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry,” Journal of the American College of Cardiology, vol. 36, no. 3, Supplement 1, pp. 1104–1109, Sep. 2000, doi: 10.1016/S0735-1097(00)00846-9. DOI: https://doi.org/10.1016/S0735-1097(00)00846-9 Google Scholar PubMed Crossref WorldCat
  34. [34]. C. M. Otto et al., “2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Dis-ease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines,” Circulation, vol. 143, no. 5, pp. e72–e227, Feb. 2021, doi: 10.1161/CIR.0000000000000923. DOI: https://doi.org/10.1161/CIR.0000000000000923 Google Scholar PubMed Crossref WorldCat
  35. [35]. Ananthakrishna Pillai, C. Ramasamy, S. G. V, and H. Kottyath, “Outcomes following balloon mitral valvuloplasty in pregnant females with mitral stenosis and significant sub valve disease with severe de-compensated heart failure,” J Interv Cardiol, vol. 31, no. 4, pp. 525–531, Aug. 2018, doi: 10.1111/joic.12507. DOI: https://doi.org/10.1111/joic.12507 Google Scholar PubMed Crossref WorldCat
  36. [36]. “Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation | New England Journal of Medicine.” Accessed: Oct. 20, 2024. [Online]. Available: https://www-nejm-org.qulib.idm.oclc.org/doi/full/10.1056/NEJMoa1805374 Google Scholar PubMed Crossref WorldCat
  37. [37]. G. W. Stone et al., “Transcatheter Mitral-Valve Repair in Patients with Heart Failure,” New England Journal of Medicine, vol. 379, no. 24, pp. 2307–2318, Dec. 2018, doi: 10.1056/NEJMoa1806640. DOI: https://doi.org/10.1056/NEJMoa1806640 Google Scholar PubMed Crossref WorldCat
  38. [38]. R. Kaddoura and M. Al-Hijji, “Transcatheter Mitral Valve Repair in Acute and Critical Cardiac Condi-tions,” Heart Views?: The Official Journal of the Gulf Heart Association, vol. 24, no. 1, p. 29, Feb. 2023, doi: 10.4103/heartviews.heartviews_73_22. DOI: https://doi.org/10.4103/heartviews.heartviews_73_22 Google Scholar PubMed Crossref WorldCat
  39. [39]. Kosaraju, V. S. Pendela, and O. Hai, “Cardiogenic Shock,” in StatPearls, Treasure Island (FL): StatPearls Publishing, 2023. Accessed: Oct. 29, 2023. [Online]. Available: http://www.ncbi.nlm.nih.gov/books/NBK482255/ Google Scholar PubMed WorldCat
  40. [40]. Y. Topilsky, “Mitral Regurgitation: Anatomy, Physiology, and Pathophysiology—Lessons Learned From Surgery and Cardiac Imaging,” Front Cardiovasc Med, vol. 7, p. 84, May 2020, doi: 10.3389/fcvm.2020.00084. DOI: https://doi.org/10.3389/fcvm.2020.00084 Google Scholar PubMed Crossref WorldCat
  41. [41]. Shankar et al., “A Clinical Update on Vasoactive Medication in the Management of Cardiogenic Shock,” Clin Med Insights Cardiol, vol. 16, p. 11795468221075064, Feb. 2022, doi: 10.1177/11795468221075064. DOI: https://doi.org/10.1177/11795468221075064 Google Scholar PubMed Crossref WorldCat
  42. [42]. Singh, S. Laribi, J. R. Teerlink, and A. Mebazaa, “Agents with vasodilator properties in acute heart fail-ure,” Eur Heart J, vol. 38, no. 5, pp. 317–325, Feb. 2017, doi: 10.1093/eurheartj/ehv755. DOI: https://doi.org/10.1093/eurheartj/ehv755 Google Scholar PubMed Crossref WorldCat
  43. [43]. K. Uhlig et al., “Inotropic agents and vasodilator strategies for the treatment of cardiogenic shock or low cardiac output syndrome,” Cochrane Database Syst Rev, vol. 11, no. 11, p. CD009669, Nov. 2020, doi: 10.1002/14651858.CD009669.pub4. DOI: https://doi.org/10.1002/14651858.CD009669.pub4 Google Scholar PubMed Crossref WorldCat
  44. [44]. A. den Uil et al., “Short-term mechanical circulatory support as a bridge to durable left ventricular assist device implantation in refractory cardiogenic shock: a systematic review and meta-analysis,” Eur J Cardi-othorac Surg, vol. 52, no. 1, pp. 14–25, Jul. 2017, doi: 10.1093/ejcts/ezx088. DOI: https://doi.org/10.1093/ejcts/ezx088 Google Scholar PubMed Crossref WorldCat
  45. [45]. J. L. Peura et al., “Recommendations for the use of mechanical circulatory support: Device strategies and patient selection: A scientific statement from the American heart association,” Circulation, vol. 126, no. 22, pp. 2648–2667, 2012, doi: 10.1161/CIR.0b013e3182769a54. DOI: https://doi.org/10.1161/CIR.0b013e3182769a54 Google Scholar PubMed Crossref WorldCat
  46. [46]. J. R. Kimman et al., “Mechanical Support in Early Cardiogenic Shock: What Is the Role of Intra-aortic Balloon Counterpulsation?,” Curr Heart Fail Rep, vol. 17, no. 5, pp. 247–260, Oct. 2020, doi: 10.1007/s11897-020-00480-0. DOI: https://doi.org/10.1007/s11897-020-00480-0 Google Scholar PubMed Crossref WorldCat
  47. [47]. S. Imaoka et al., “Impella Support as a Bridge to Surgery for Severe Mitral Regurgitation With Cardio-genic Shock,” Circ Rep, vol. 3, no. 3, pp. 178–181, doi: 10.1253/circrep.CR-21-0016. DOI: https://doi.org/10.1253/circrep.CR-21-0016 Google Scholar PubMed Crossref WorldCat
  48. [48]. “Left Impella®-device as bridge from cardiogenic shock with acute, severe mitral regurgitation to Mitra-Clip®-procedure: a new option for critically ill patients - PubMed.” Accessed: Oct. 20, 2024. [Online]. Available: https://pubmed-ncbi-nlm-nih-gov.qulib.idm.oclc.org/33620436/ Google Scholar PubMed WorldCat
  49. [49]. P. Villablanca et al., “Mechanical Circulatory Support in Cardiogenic Shock due to Structural Heart Dis-ease,” Interv Cardiol Clin, vol. 10, no. 2, pp. 221–234, Apr. 2021, doi: 10.1016/j.iccl.2020.12.007. DOI: https://doi.org/10.1016/j.iccl.2020.12.007 Google Scholar PubMed Crossref WorldCat
  50. [50]. S. S. Goel et al., “Prevalence and outcomes of unoperated patients with severe symptomatic mitral regur-gitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need,” J Am Coll Cardiol, vol. 63, no. 2, pp. 185–186, Jan. 2014, doi: 10.1016/j.jacc.2013.08.723. DOI: https://doi.org/10.1016/j.jacc.2013.08.723 Google Scholar PubMed Crossref WorldCat
  51. [51]. S. V. Arnold et al., “Health Status After Transcatheter Mitral-Valve Repair in Heart Fail-ure and Secondary Mitral Regurgitation: COAPT Trial,” Journal of the American College of Cardiology, vol. 73, no. 17, pp. 2123–2132, May 2019, doi: 10.1016/j.jacc.2019.02.010. DOI: https://doi.org/10.1016/j.jacc.2019.02.010 Google Scholar PubMed Crossref WorldCat
  52. [52]. P. Kovach, S. Bell, A. Kataruka, M. Reisman, and C. Don, “Outcomes of urgent/emergent transcatheter mitral valve repair (MitraClip): A single center experience,” Catheter Cardiovasc Interv, vol. 97, no. 3, pp. E402–E410, Feb. 2021, doi: 10.1002/ccd.29084. DOI: https://doi.org/10.1002/ccd.29084 Google Scholar PubMed Crossref WorldCat
  53. [53]. S. Aldrugh, N. Kakouros, and W. Qureshi, “National prevalence and outcomes of different mitral valve interventions for mitral regurgitation among patients with cardiogenic shock: an analysis of the national readmission database 2010–2018,” European Heart Journal, vol. 42, no. Supplement_1, p. ehab724.2212, Oct. 2021, doi: 10.1093/eurheartj/ehab724.2212. DOI: https://doi.org/10.1093/eurheartj/ehab724.2212 Google Scholar PubMed Crossref WorldCat
  54. [54]. C.-W. Lee et al., “Feasibility of the transcatheter mitral valve repair for patients with severe mitral regur-gitation and endangered heart failure,” Journal of the Formosan Medical Association, vol. 120, no. 1, Part 2, pp. 452–459, Jan. 2021, doi: 10.1016/j.jfma.2020.04.035. DOI: https://doi.org/10.1016/j.jfma.2020.04.035 Google Scholar PubMed Crossref WorldCat
  55. [55]. R. Estévez-Loureiro et al., “Use of MitraClip for mitral valve repair in patients with acute mitral regurgi-tation following acute myocardial infarction: Effect of cardiogenic shock on outcomes (IREMMI Regis-try),” Catheter Cardiovasc Interv, vol. 97, no. 6, pp. 1259–1267, May 2021, doi: 10.1002/ccd.29552. DOI: https://doi.org/10.1002/ccd.29552 Google Scholar PubMed Crossref WorldCat
  56. [56]. Haberman et al., “Safety and Feasibility of MitraClip Implantation in Patients with Acute Mitral Regur-gitation after Recent Myocardial Infarction and Severe Left Ventricle Dysfunction,” J Clin Med, vol. 10, no. 9, p. 1819, Apr. 2021, doi: 10.3390/jcm10091819. DOI: https://doi.org/10.3390/jcm10091819 Google Scholar PubMed Crossref WorldCat
  57. [57]. K. Flint, A. Brieke, D. Wiktor, and J. Carroll, “Percutaneous edge-to-edge mitral valve repair may rescue select patients in cardiogenic shock: Findings from a single center case series,” Catheter Cardiovasc In-terv, vol. 94, no. 2, pp. E82–E87, Aug. 2019, doi: 10.1002/ccd.28089. DOI: https://doi.org/10.1002/ccd.28089 Google Scholar PubMed Crossref WorldCat
  58. [58]. G. H. L. Tang, R. Estevez-Loureiro, Y. Yu, J. B. Prillinger, S. Zaid, and M. A. Psotka, “Survival Fol-lowing Edge-to-Edge Transcatheter Mitral Valve Repair in Patients With Cardiogenic Shock: A Nation-wide Analysis,” J Am Heart Assoc, vol. 10, no. 8, p. e019882, Apr. 2021, doi: 10.1161/JAHA.120.019882. DOI: https://doi.org/10.1161/JAHA.120.019882 Google Scholar PubMed Crossref WorldCat
  59. [59]. C.-Y. So et al., “Transcatheter Edge-to-Edge Repair for Acute Mitral Regurgitation With Cardiogenic Shock Secondary to Mechanical Complication,” Cardiovasc Revasc Med, vol. 45, pp. 44–50, Dec. 2022, doi: 10.1016/j.carrev.2022.07.003. DOI: https://doi.org/10.1016/j.carrev.2022.07.003 Google Scholar PubMed Crossref WorldCat
  60. [60]. G. Falasconi et al., “Use of edge-to-edge percutaneous mitral valve repair for severe mitral regurgitation in cardiogenic shock: A multicenter observational experience (MITRA-SHOCK study),” Catheter Cardio-vasc Interv, vol. 98, no. 1, pp. E163–E170, Jul. 2021, doi: 10.1002/ccd.29683. DOI: https://doi.org/10.1002/ccd.29683 Google Scholar PubMed Crossref WorldCat
  61. [61]. “Percutaneous Mitral Repair as Salvage Therapy in Patients With Mitral Regurgitation and Refractory Cardiogenic Shock - PubMed.” Accessed: Oct. 20, 2024. [Online]. Available: https://pubmed-ncbi-nlm-nih-gov.qulib.idm.oclc.org/31694413/ Google Scholar PubMed WorldCat
  62. [62]. R. Cheng et al., “Percutaneous Mitral Repair for Patients in Cardiogenic Shock Requiring Inotropes and Temporary Mechanical Circulatory Support,” JACC Cardiovasc Interv, vol. 12, no. 23, pp. 2440–2441, Dec. 2019, doi: 10.1016/j.jcin.2019.05.042. DOI: https://doi.org/10.1016/j.jcin.2019.05.042 Google Scholar PubMed Crossref WorldCat
  63. [63]. S. Garcia et al., “Percutaneous Mitral Valve Repair With MitraClip in Inoperable Patients With Severe Mitral Regurgitation Complicated by Cardiogenic Shock,” J Invasive Cardiol, vol. 32, no. 6, pp. 228–231, Jun. 2020. DOI: https://doi.org/10.25270/jic/19.00453 Google Scholar PubMed WorldCat
  64. [64]. R. G. Jung et al., “Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation: A Patient-Level, Multicenter Analysis,” JACC Cardiovasc Interv, vol. 14, no. 1, pp. 1–11, Jan. 2021, doi: 10.1016/j.jcin.2020.08.037. DOI: https://doi.org/10.1016/j.jcin.2020.11.008 Google Scholar PubMed Crossref WorldCat
  65. [65]. S. Parlow et al., “Transcatheter mitral valve repair for inotrope dependent cardiogenic shock - Design and rationale of the CAPITAL MINOS trial,” Am Heart J, vol. 254, pp. 81–87, Dec. 2022, doi: 10.1016/j.ahj.2022.08.008. DOI: https://doi.org/10.1016/j.ahj.2022.08.008 Google Scholar PubMed Crossref WorldCat
  66. [66]. C. Fraccaro et al., “Transcatheter interventions for left-sided valvular heart disease complicated by cardio-genic shock: a consensus statement from the European Association of Percutaneous Cardiovascular Inter-ventions (EAPCI) in collaboration with the Association for Acute Cardiovascular Care (ACVC) and the ESC Working Group on Cardiovascular Surgery,” EuroIntervention, vol. 19, no. 8, pp. 634–651, Oct. 2023, doi: 10.4244/EIJ-D-23-00473. DOI: https://doi.org/10.4244/EIJ-D-23-00473 Google Scholar PubMed Crossref WorldCat
  67. [67]. S. A. Al-Asmi et al., “Transcatheter Mitral Valve Repair with MitraClip®: A Nationwide Experience,” Heart Views, vol. 24, no. 4, pp. 179–187, 2023, doi: 10.4103/heartviews.heartviews_90_23. DOI: https://doi.org/10.4103/heartviews.heartviews_90_23 Google Scholar PubMed Crossref WorldCat
  68. [68]. M. Orban et al., “Transcatheter edge-to-edge repair for secondary mitral regurgitation with third-generation devices in heart failure patients – results from the Global EXPAND Post-Market study,” European Jour-nal of Heart Failure, vol. 25, no. 3, pp. 411–421, 2023, doi: 10.1002/ejhf.2770. DOI: https://doi.org/10.1002/ejhf.2770 Google Scholar PubMed Crossref WorldCat
  69. [69]. R. S. von Bardeleben et al., “Real-World Outcomes of Fourth-Generation Mitral Transcatheter Repair: 30-Day Results From EXPAND G4,” JACC Cardiovasc Interv, vol. 16, no. 12, pp. 1463–1473, Jun. 2023, doi: 10.1016/j.jcin.2023.05.013. DOI: https://doi.org/10.1016/j.jcin.2023.05.013 Google Scholar PubMed Crossref WorldCat
  70. [70]. B. Levy, J. Buzon, and A. Kimmoun, “Inotropes and vasopressors use in cardiogenic shock: when, which and how much?,” Current Opinion in Critical Care, vol. 25, no. 4, p. 384, Aug. 2019, doi: 10.1097/MCC.0000000000000632. DOI: https://doi.org/10.1097/MCC.0000000000000632 Google Scholar PubMed Crossref WorldCat
  71. [71]. J. E. Bloom, W. Chan, D. M. Kaye, and D. Stub, “State of Shock: Contemporary Vasopressor and In-otrope Use in Cardiogenic Shock,” Journal of the American Heart Association, vol. 12, no. 15, p. e029787, Aug. 2023, doi: 10.1161/JAHA.123.029787. DOI: https://doi.org/10.1161/JAHA.123.029787 Google Scholar PubMed Crossref WorldCat
  72. [72]. V. Atti et al., “A Comprehensive Review of Mechanical Circulatory Support Devices,” Heart Int, vol. 16, no. 1, pp. 37–48, Mar. 2022, doi: 10.17925/HI.2022.16.1.37. DOI: https://doi.org/10.17925/HI.2022.16.1.37 Google Scholar PubMed Crossref WorldCat
  73. [73]. B. Worku, A. R. de Biasi, I. Gulkarov, S.-C. Wong, and A. Salemi, “Transapical Mitral Valve-In-Valve Implantation for Patients in Cardiogenic Shock,” The Annals of Thoracic Surgery, vol. 99, no. 5, pp. e103–e105, May 2015, doi: 10.1016/j.athoracsur.2015.01.046. DOI: https://doi.org/10.1016/j.athoracsur.2015.01.046 Google Scholar PubMed Crossref WorldCat
  74. [74]. M. Litmanovitch, G. M. Joynt, J. Skoularigis, and J. Lipman, “Emergency percutaneous balloon mitral valvotomy in a patient with septic shock,” Chest, vol. 108, no. 2, pp. 570–572, Aug. 1995, doi: 10.1378/chest.108.2.570. DOI: https://doi.org/10.1378/chest.108.2.570 Google Scholar PubMed Crossref WorldCat
  75. [75]. W. H. Chow and T. C. Chow, “Percutaneous balloon mitral valvotomy as a bridge to elective mitral valve replacement,” Cathet Cardiovasc Diagn, vol. 45, no. 1, p. 102, Sep. 1998, doi: 10.1002/(sici)1097-0304(199809)45:1<102::aid-ccd26>3.0.co;2-o. DOI: https://doi.org/10.1002/(SICI)1097-0304(199809)45:1<102::AID-CCD26>3.0.CO;2-O Google Scholar PubMed Crossref WorldCat
  76. [76]. J. S. Dugal, V. Jetley, J. S. Sabharwal, S. Sofat, and C. Singh, “Life-saving PTMC for critical calcific mitral stenosis in cardiogenic shock with balloon impasse,” Int J Cardiovasc Intervent, vol. 5, no. 3, pp. 172–174, 2003. DOI: https://doi.org/10.1080/14628840310017401 Google Scholar PubMed WorldCat
  77. [77]. S. Strick et al., “[Emergent percutaneous mitral valve repair with Inoue balloon-catheter in severe mitral stenosis and cardiogenic shock],” Dtsch Med Wochenschr, vol. 119, no. 33, pp. 1110–1114, Aug. 1994, doi: 10.1055/s-2008-1058810. DOI: https://doi.org/10.1055/s-2008-1058810 Google Scholar PubMed Crossref WorldCat
  78. [78]. M. Notrica et al., “Life-saving Percutaneous Mitral Valvuloplasty on a Pregnant Woman with Refractory Cardiogenic Shock,” Heart, Lung and Circulation, vol. 18, no. 4, pp. 301–304, Aug. 2009, doi: 10.1016/j.hlc.2007.12.008. DOI: https://doi.org/10.1016/j.hlc.2007.12.008 Google Scholar PubMed Crossref WorldCat
  79. [79]. J. Endrys, A. G. Habashy, and N. Hayat, “Life-saving balloon mitral valvuloplasty in patient with cardi-ogenic shock after cardiac arrest,” J Invasive Cardiol, vol. 13, no. 11, pp. 752–754, Nov. 2001. Google Scholar PubMed WorldCat

Similar Articles

1-10 of 16

You may also start an advanced similarity search for this article.

Most read articles by the same author(s)